We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.


The West Blog

Latest Post

March 12, 2018

Evolution in Biologic Drug Products – Need for Administration of High Viscosities

Biologic drug products are not new &ndash; their development began decades ago; the first monoclonal antibody was commercialized in 1986.<sup> [1]</sup> With the increasing availability of genetic information, and better understanding of subcellular cascades and disease processes, the number of biologic drug products available has increased substantially in response to an exponential growth in targets. <sup>[2]</sup>
Frederike Ferber

Frederike Ferber

Specialist, TCS, Commercial, EU

Subscribe to receive the latest blog post
Previous Posts
Pannel discussion at NIBRT

March 14, 2017

West and NIBRT Host Educational Event

Brian Kenny

Brian Kenny

Director, Emerging Biotech, EMEA, Sales

NovaPure 1 mL and 1-3 mL plungers

February 06, 2017

NovaPure® Plungers for Biologic Applications

Christa Jansen-Otten

Christa Jansen-Otten, Director, Product Management

Petra Huhn, Manager, TCS Europe

Subcutaneous Bilogics Pipeline Card

October 11, 2016

Important Concerns Regarding Volume and Viscosity Part 2

Royce Brockett

Royce Brockett

Senior Product Manager